Mr. Littlejohn, the issue here as we understand it is about the stable supply of isotopes in the short and the long term being critical for our patients. I would like further clarity on this comment—I know it has been asked, but I would like clarity on it.
How does Canada get its fair share? Is it based on price point, customer needs...? With the limited supply that we are dealing with, how does Canada compare with other jurisdictions?